Acadia Pharmaceuticals | ACAD - 销售毛利

股票价格

20.73

每天变化

0.01 0.05%

每月一次

-16.17%

每年

23.47%

Q1 预测

19.99

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.44B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	销售毛利	更改		日
Acadia Pharmaceuticals	USD 257.76M		778K	2025-12
ALKERMES	USD 338.34M		72.51M	2025-12
Alnylam Pharmaceuticals	USD 829.31M		219.56M	2025-12
Biogen	USD 1.65B		34.6M	2025-12
BioMarin Pharmaceutical	USD 713.01M		81.81M	2025-12
Bristol-Myers Squibb	USD 8.79B		110M	2025-09
Cara Therapeutics	USD 2.57M		1.11M	2025-03
Corcept Therapeutics	USD 199.58M		3.46M	2025-12
Cytokinetics	USD 17.76M		15.82M	2025-12
Eisai	JPY 168.85B		17.02B	2025-12
Eli Lilly	USD 14.59B		1.48B	2025-09
Incyte	USD 1.39B		118.68M	2025-12
J&J	USD 16.6B		118M	2025-12
Moderna	USD 226M		583M	2025-12
Neurocrine Biosciences	USD 787.9M		7M	2025-12
Pfizer	USD 3.54B		7.61B	2025-09
Prothena	USD 21K		2.39M	2025-12
PTC Therapeutics	USD 148.38M		39.31M	2025-12
Sarepta Therapeutics	USD 43.55M		204.36M	2025-12
Ultragenyx Pharmaceutical	USD 178M		46.06M	2025-12
Vanda Pharmaceuticals	USD 50.6M		5.5M	2024-12
Vertex Pharmaceuticals	USD 2.72B		62.4M	2025-12